
News|Podcasts|April 29, 2025
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
Author(s)Alexandra Gerlach, Content Producer
Pharmacists discuss how drug design impacts drug efficacy and indications for HER2-low and -ultra-low breast cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
Q&A: Pharmacy Technicians and the Future of Obesity Management
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
How Clinical Pharmacists Optimize Obstructive Hypertrophic Cardiomyopathy Care
5


































































































































